Literature DB >> 14500351

Phosphorylation of beta-catenin at S33, S37, or T41 can occur in the absence of phosphorylation at T45 in colon cancer cells.

Zhenghe Wang1, Bert Vogelstein, Kenneth W Kinzler.   

Abstract

Several previous studies in a variety of systems have suggested that phosphorylation at S45 of beta-catenin is essential for subsequent phosphorylation at more NH(2)-terminal residues. Using genetic models expressing beta-catenin under endogenous regulation, we find that phosphorylation of beta-catenin at S45 is not required for phosphorylation at residues S33, S37, or T41 in human colon cancer cells, in contrast to prevailing models. These findings suggest that there are important cell- and organism-specific differences in even the most highly conserved signaling pathways and emphasize the importance of examining these pathways in the cancer cell types in which the pathways are actually deregulated.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14500351

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  25 in total

1.  Microglial integrity is maintained by erythropoietin through integration of Akt and its substrates of glycogen synthase kinase-3beta, beta-catenin, and nuclear factor-kappaB.

Authors:  Faqi Li; Zhao Zhong Chong; Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2006-08       Impact factor: 1.990

2.  Beta-Catenin Mutation with Complex Chromosomal Changes in Desmoid Tumor of the Scalp: A Case Report.

Authors:  Gary Liu; Howard L Weiner; William C Pederson; Lesley Davies; Edward P Buchanan
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2018-11-16

3.  Molecular imaging of glycogen synthase kinase-3beta and casein kinase-1alpha kinases.

Authors:  Shyam Nyati; Rajesh Ranga; Brian D Ross; Alnawaz Rehemtulla; Mahaveer Swaroop Bhojani
Journal:  Anal Biochem       Date:  2010-06-16       Impact factor: 3.365

4.  Blocking Wnt signaling by SFRP-like molecules inhibits in vivo cell proliferation and tumor growth in cells carrying active β-catenin.

Authors:  E Lavergne; I Hendaoui; C Coulouarn; C Ribault; J Leseur; P-A Eliat; S Mebarki; A Corlu; B Clément; O Musso
Journal:  Oncogene       Date:  2010-09-20       Impact factor: 9.867

5.  Cellular demise and inflammatory microglial activation during beta-amyloid toxicity are governed by Wnt1 and canonical signaling pathways.

Authors:  Zhao Zhong Chong; Faqi Li; Kenneth Maiese
Journal:  Cell Signal       Date:  2007-01-09       Impact factor: 4.315

6.  Consistent activation of the β-catenin pathway by Salmonella type-three secretion effector protein AvrA in chronically infected intestine.

Authors:  Rong Lu; Xingyin Liu; Shaoping Wu; Yinglin Xia; Yong-Guo Zhang; Elaine O Petrof; Erika C Claud; Jun Sun
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-09-13       Impact factor: 4.052

7.  Identification of STAT3 as a substrate of receptor protein tyrosine phosphatase T.

Authors:  Xiaodong Zhang; Ailan Guo; Jianshi Yu; Anthony Possemato; Yueting Chen; Weiping Zheng; Roberto D Polakiewicz; Kenneth W Kinzler; Bert Vogelstein; Victor E Velculescu; Zhenghe John Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-21       Impact factor: 11.205

8.  Phosphorylation and ubiquitination of oncogenic mutants of beta-catenin containing substitutions at Asp32.

Authors:  Mohamed Al-Fageeh; Qingjie Li; W Mohaiza Dashwood; Melinda C Myzak; Roderick H Dashwood
Journal:  Oncogene       Date:  2004-06-17       Impact factor: 9.867

9.  Groucho binds two conserved regions of LEF-1 for HDAC-dependent repression.

Authors:  Laura Arce; Kira T Pate; Marian L Waterman
Journal:  BMC Cancer       Date:  2009-05-21       Impact factor: 4.430

10.  The imprinted gene PEG3 inhibits Wnt signaling and regulates glioma growth.

Authors:  Xiuli Jiang; Yi Yu; Hong Wei Yang; Nathalie Y R Agar; Laura Frado; Mark D Johnson
Journal:  J Biol Chem       Date:  2010-01-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.